FME logo
FME
Fresenius Medical Care

Aging Demographics And Home Dialysis Solutions Will Transform Care Delivery

Published
18 Nov 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
€50.59
14.4% undervalued intrinsic discount
14 Aug
€43.31
Loading
1Y
27.3%
7D
1.8%

Author's Valuation

€50.6

14.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates8

Shared on01 May 25
Fair value Increased 5.86%

Read more

Shared on23 Apr 25
Fair value Decreased 0.81%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Decreased 6.02%

AnalystConsensusTarget has increased revenue growth from 3.0% to 3.6%.

Read more

Shared on09 Apr 25
Fair value Increased 6.03%

Read more

Shared on02 Apr 25
Fair value Increased 0.81%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25
Fair value Increased 0.46%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Increased 1.42%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on12 Mar 25
Fair value Increased 1.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more